Ivet Elias 1 , 2 , 3 , Sylvie Franckhauser 1 , 3 , Tura Ferré 1 , 3 , Laia Vilà 1 , 2 , 3 , Sabrina Tafuro 1 , 3 , † , Sergio Muñoz 1 , 2 , 3 , Carles Roca 1 , 2 , 3 , David Ramos 1 , 4 , Anna Pujol 1 , 2 , 3 , Efren Riu 1 , 2 , 3 , Jesús Ruberte 1 , 3 , 4 , Fatima Bosch 1 , 2 , 3
15 June 2012
During the expansion of fat mass in obesity, vascularization of adipose tissue is insufficient to maintain tissue normoxia. Local hypoxia develops and may result in altered adipokine expression, proinflammatory macrophage recruitment, and insulin resistance. We investigated whether an increase in adipose tissue angiogenesis could protect against obesity-induced hypoxia and, consequently, insulin resistance. Transgenic mice overexpressing vascular endothelial growth factor (VEGF) in brown adipose tissue (BAT) and white adipose tissue (WAT) were generated. Vessel formation, metabolism, and inflammation were studied in VEGF transgenic mice and wild-type littermates fed chow or a high-fat diet. Overexpression of VEGF resulted in increased blood vessel number and size in both WAT and BAT and protection against high-fat diet–induced hypoxia and obesity, with no differences in food intake. This was associated with increased thermogenesis and energy expenditure. Moreover, whole-body insulin sensitivity and glucose tolerance were improved. Transgenic mice presented increased macrophage infiltration, with a higher number of M2 anti-inflammatory and fewer M1 proinflammatory macrophages than wild-type littermates, thus maintaining an anti-inflammatory milieu that could avoid insulin resistance. These studies suggest that overexpression of VEGF in adipose tissue is a potential therapeutic strategy for the prevention of obesity and insulin resistance.